Product NDC: | 14537-408 |
Proprietary Name: | Isoplate |
Non Proprietary Name: | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, and POTASSIUM PHOSPHATE, MONOBASIC |
Active Ingredient(s): | .03; .037; .00082; .37; .53; .5; .012 g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL & nbsp; SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, and POTASSIUM PHOSPHATE, MONOBASIC |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 14537-408 |
Labeler Name: | Terumo BCT Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BN090067 |
Marketing Category: | NDA |
Start Marketing Date: | 20130305 |
Package NDC: | 14537-408-50 |
Package Description: | 24 CONTAINER in 1 CASE (14537-408-50) > 500 mL in 1 CONTAINER |
NDC Code | 14537-408-50 |
Proprietary Name | Isoplate |
Package Description | 24 CONTAINER in 1 CASE (14537-408-50) > 500 mL in 1 CONTAINER |
Product NDC | 14537-408 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, and POTASSIUM PHOSPHATE, MONOBASIC |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20130305 |
Marketing Category Name | NDA |
Labeler Name | Terumo BCT Ltd. |
Substance Name | MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC |
Strength Number | .03; .037; .00082; .37; .53; .5; .012 |
Strength Unit | g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL |
Pharmaceutical Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA] |